You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單日新增不足8.5萬宗新冠 拜登指過去六週確診減少47%
阿思達克 10-15 15:19
美國新冠疫情緩和。據美國約翰霍普斯大學統計,截至美國西岸時間昨日(12日)午夜,美國累計新冠確診44,767,938宗,單日新增84,888宗。累計新冠死亡721,567宗,單日新增2,040宗。 美國總統拜登表示,新冠疫苗接種計劃有效減少新冠確診及入院率,又指過去六週每日確診及入院數字分別減少47%及38%。他指美國仍有6,600萬名合資格人士未接種疫苗,情況不能接受。美國目前有1.88億人完成接種新冠疫苗,佔總人口57%。 另外,美國食品及藥物管理局(FDA)顧問小組通過準許65歲或以上長者、長期病患及高危羣組人士,接種第三劑莫德納(MRNA.US)新冠疫苗,該加強劑分量將爲首兩劑的一半,接種第二劑後半年始可接種第三劑。有關決定仍須經另一重顧問小組審批通過才能落實。至於是否批準接種第二劑強生(JNJ.US)新冠疫苗,則待今日(15日)開會決定。 美國過去八日每日新冠疫情統計: 日期│累計確診│單日新增確診│累計死亡│單日新增死亡 10月14日(四)│44,767,938宗│+ 84,888宗│721,567宗│+2,040宗 10月13日(三)│44,683,050宗│+120,263宗│719,527宗│+3,050宗 10月12日(二)│44,562,287宗│+106,828宗│716,477宗│+2,420宗 10月11日(一)│44,455,959宗│+116,129宗│714,057宗│+ 707宗 10月10日(日)│44,339,830宗│+ 22,277宗│713,350宗│+ 376宗 10月 9日(六)│44,317,553宗│+ 27,460宗│712,974宗│+ 279宗 10月 8日(五)│44,290,093宗│+131,104宗│712,695宗│+2,517宗 10月 7日(四)│44,158,989宗│+100,108宗│710,178宗│+2,390宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account